05 Mar 26
We are living in a fast-changing era in the field of respiratory care. The COVID-19 pandemic significantly increased awareness of respiratory diseases and highlighted the benefits of telemedicine. Now, several years later, we are witnessing substantial changes that affect both physicians and patients.
For distributors, staying informed about rapidly evolving technologies, along with the changing needs of patients worldwide, is essential.
In this article, we take a closer look at the current market trends in respiratory care devices and what they mean for distributors.
According to ResearchAndMarkets.com, a leading source of international market research and data, the global respiratory care devices market is projected to grow from USD 23.6 billion in 2025 to USD 33.6 billion by 2030, with a CAGR of 7.3%.
This growth is largely driven by the increasing incidence of respiratory diseases, influenced by factors such as:
Among respiratory conditions, COPD is expected to account for the largest market share. As a progressive and irreversible disease, it requires continuous monitoring and long-term respiratory treatment.
Key technologies expected to dominate the coming years are those that enable better care, especially for elderly patients, including:
These core technologies are increasingly enhanced by complementary digital solutions such as:
This evolving ecosystem creates new opportunities for distributors who can meet the growing demand for home-care devices and self-testing solutions.
Telehealth is actively reshaping the way respiratory care is delivered. Remote patient monitoring (RPM) systems for respiratory conditions are becoming more widespread, and the integration of telehealth features into respiratory devices is quickly becoming standard practice.
As a result, reliable connectivity and user-friendly interfaces, for both patients and healthcare professionals, are now essential. These features enable continuous monitoring of chronic respiratory conditions, support early intervention, and help reduce hospital readmissions.
Looking ahead, the following trends are expected to gain momentum.
Compact and lightweight respiratory devices improve patient mobility and independence, contributing to better clinical outcomes and driving further miniaturization.
Internet of Things (IoT) technologies enable real-time monitoring and seamless data sharing between patients and healthcare providers. Smart devices are increasingly required for fast, reliable testing, as well as compliance tracking and clinical monitoring.
Continuous data collection and real-time insights allow physicians to tailor treatments to individual patient needs. Personalized therapy plans can significantly enhance treatment effectiveness and patient outcomes.
With over 30 years of experience in spirometry and oximetry, MIR is a dynamic MedTech company strongly committed to research and innovation. Its product portfolio includes state-of-the-art devices designed for both professional and personal healthcare environments.
MIR builds long-term partnerships with distributors and sales representatives by offering dedicated support, training, and commercial care. Each year, more than 15,000 additional healthcare professionals request MIR products through their distribution networks.
Discover the advantages of becoming an official MIR dealer: contact us today.
